Ibrance 125 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26FT2ZG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,555
Award facts
- Contract value 100% obligated
- $8,555.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 30, 2026, for Ibrance 125 mg tablets (7-count package).
The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, a global pharmaceutical supply vehicle. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of April 20, 2026.
Quick answers
Who was awarded contract SPE2DR26FT2ZG?
SPE2DR26FT2ZG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 30, 2026.
How much is contract SPE2DR26FT2ZG worth?
The government has obligated $8,555 on SPE2DR26FT2ZG.
Is contract SPE2DR26FT2ZG an order under another contract?
Yes. SPE2DR26FT2ZG is a delivery order under SPE2DR25D3109, an indefinite delivery contract.
Was contract SPE2DR26FT2ZG competed?
The extent of competition for SPE2DR26FT2ZG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award